2nd Edition of Cell & Gene Therapy World Conference(CGTWC) 2026

Scientific Sessions

The Cell Therapy in Cancer Treatment

The session will explore the latest breakthroughs in cell-based therapies, including CAR-T and TCR therapies, and their growing role in cancer treatment. With a focus on the significant progress made in targeting difficult cancers, the session will also address the ongoing challenges in improving patient outcomes and managing safety concerns like cytokine release syndrome (CRS) and relapse. At Cell & Gene Therapy World Conference 2026, experts will explore the potential of combining cell therapies with other treatments to enhance efficacy. Additionally, the session will consider the ethical implications, such as equitable access to these therapies and long-term patient safety.

Related Sessions

CRISPR Cas9 and Beyond: Emerging Genome Editing Platforms
Precision Genome Editing: From Target Discovery to Clinical Application
Engineering the Immune System: Gene and Cell Based Modulation
Non Viral Gene Delivery Strategies: Safety, Scalability, and Translation
Stem Cell Derived Therapeutics: iPSCs, Organoids and Tissue Engineering
Allogeneic vs Autologous Cell Therapies: Manufacturing, Efficacy, and Access
Manufacturing for Personalized Medicine: Customised Cell Products at Scale
Analytics, Potency Assays, and Rapid Release Strategies
CGTs for Monogenic Disorders: Delivering the Cure
Gene and Cell Therapies in Oncology: CAR T, NK, TCR, Oncolytic Approaches
Neurological and Neurodegenerative Disease Applications of CGTs
Market Access, Health Economics, and Reimbursement in CGT
Global Access and Equity: Bridging the CGT Innovation Gap
The Future Landscape of Cell and Gene Therapies: 2030 and Beyond
Cell and Gene Therapy Clinical Development
Cell and Gene Therapy Pipeline Analysis